C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
08/2011
08/24/2011	CN101248061B Hydrates of alkaline-earth salts of irbesartan and the preparation thereof
08/24/2011	CN101213191B Antifungal triazole derivatives
08/23/2011	US8003805 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/23/2011	US8003789 Activity against strains having acquired resistance nonnucleoside reverse transcriptase inhibitors; human alpha1 acid glycoprotein nonbinding; such as 4-[[(5-bromo-4,6-dichloro)-2-pyrimidinyl]amino]-benzonitrile
08/23/2011	US8003718 Oligomeric sterically hindered amines and their use as polymer stabilisers
08/23/2011	US8003693 Modulation of anxiety through blockade of anandamide hydrolysis
08/23/2011	US8003659 Macrocyclic serine protease inhibitors
08/23/2011	US8003653 Imidazolidinone compounds useful as β-secretase inhibitors for the treatment of Alzheimer's disease
08/23/2011	US8003650 Hydrazide compound and harmful arthropod-controlling agent containing the same
08/23/2011	US8003643 Inhibitors of Akt activity
08/23/2011	US8003638 7-pyrazolylbenzazepines having affinity for D3 receptor
08/23/2011	CA2483162C Use of 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino benzo[b]thiophene-2-carboxylic acid derivatives as il-4 inhibitors
08/18/2011	WO2011100325A2 Polymorphs of sunitinib salts
08/18/2011	WO2011098776A1 5-ht receptor modulators
08/18/2011	WO2011098603A1 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors
08/18/2011	WO2011098408A2 Hydrazine-substituted anthranilic acid derivatives
08/18/2011	WO2011082267A8 Substituted triazolo-pyrazine compounds
08/18/2011	WO2011080751A3 α4β2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
08/18/2011	WO2011047319A3 Antimicrobial compounds and methods of making and using the same
08/18/2011	US20110202942 Optical information recording medium, method of recording information and photosensitizer
08/18/2011	US20110201812 Process for the manufacture of an indolinone derivative
08/18/2011	US20110201640 Tricyclic compound
08/18/2011	US20110201626 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
08/18/2011	US20110201621 Angiotensin ii receptor antagonists
08/18/2011	US20110201616 Sulfonamide compounds or salts thereof
08/18/2011	US20110201606 Pyrimidine derivatives
08/18/2011	US20110201605 Heteroaryl substituted piperidines
08/18/2011	US20110201599 CDK Modulators
08/18/2011	US20110201592 Therapeutic Oxy-Phenyl-Aryl Compounds and Their Use
08/18/2011	US20110201590 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
08/18/2011	US20110201584 Certain chemical entities, compositions, and methods
08/18/2011	US20110201580 Pyrrolidine derivatives
08/18/2011	US20110201563 Chimeric small molecules for the recruitment of antibodies to cancer cells
08/18/2011	US20110201555 Novel estrogen receptor ligands
08/18/2011	US20110201120 Method for introducing gene into cell, and composition for use in the method
08/18/2011	US20110200547 Cosmetic composition, compound and cosmetic treatment method
08/18/2011	US20110200536 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri)
08/18/2011	US20110197969 Methods and intermediates for the synthesis of dipyrrin-substituted porphyrinic macrocycles
08/18/2011	CA2789806A1 5-ht receptor modulators
08/17/2011	EP2357175A1 isoquinoline derivatives AND THEIR USE IN INCREASING ENDOGENEOUS ERYTHROPOIETIN
08/17/2011	EP2357173A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them
08/17/2011	EP2357169A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
08/17/2011	EP2356111A1 Compounds for the treatment of inflammatory disorders
08/17/2011	EP2356110A1 Quinazolinamide derivatives
08/17/2011	EP2356108A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
08/17/2011	EP2356106A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
08/17/2011	EP2188268B1 Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
08/17/2011	EP1812389B1 Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
08/17/2011	EP1797069B1 Hiv inhibiting 5-heterocyclyl pyrimidines
08/17/2011	EP1797048B1 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines
08/17/2011	EP1781619B1 Sigma receptor inhibitors
08/17/2011	EP1771441B1 Novel carboxamides for use as xa inhibitors
08/17/2011	EP1761505B1 Pyrimidine urea derivatives as kinase inhibitors
08/17/2011	EP1572200B1 Aminoindazole derivatives and use thereof as kinase inhibitors
08/17/2011	EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
08/17/2011	EP1246808B1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
08/17/2011	EP0853618B1 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n- (aminoiminomethyl)phenylalkyl -azaheterocyclylamide compounds
08/17/2011	CN1913886B 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
08/17/2011	CN1910156B Malononitrile compound as pesticide
08/17/2011	CN1898232B Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
08/17/2011	CN1549717B Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, and pharmaceutical uses
08/17/2011	CN102159569A Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for PDT
08/17/2011	CN102159568A 2-[1H-Benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
08/17/2011	CN102159553A Targeted nitroxide agents
08/17/2011	CN102159548A Amide compounds useful in therapy
08/17/2011	CN102159207A Substituted pyrrolidine-2-carboxamides
08/17/2011	CN102153606A Nucleoside derivatives as well as stereo isomers, pharmaceutically acceptable salts and application thereof
08/17/2011	CN102153544A Preparation method and application of novel tyrosine kinase inhibitors
08/17/2011	CN102153543A Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
08/17/2011	CN102153542A Ionizing radiation damage protection medicament
08/17/2011	CN102153540A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/17/2011	CN102153539A 3-aminopyrrolidine derivatives as modulators of chemokine receptors
08/17/2011	CN102151273A 2,4,6-triamino-1,3,5-triazine derivative
08/17/2011	CN102151270A Pyrimidine derivatives for the prevention of HIV infection
08/17/2011	CN101284814B Method for producing acrylonitrile compound
08/17/2011	CN101230059B Bicycle aza alkyl derivative, preparation method and use in medicine thereof
08/17/2011	CN101184728B Peptide deformylase (PDF) inhibitors 4
08/16/2011	US7999117 Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
08/16/2011	US7999102 Cross-linked cyclic amine compounds and agents for pest control
08/16/2011	US7998969 Non-nucleoside reverse transcriptase inhibitors
08/16/2011	US7998963 Arylpiperazine derivatives and uses thereof
08/16/2011	US7998961 For treating conditions associated with UDP-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC)
08/16/2011	US7998959 Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
08/16/2011	CA2624749C Pyrimidine amide compounds as pgds inhibitors
08/16/2011	CA2590261C Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
08/16/2011	CA2482655C Substituted indoles
08/16/2011	CA2464770C Compound
08/16/2011	CA2458009C Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
08/11/2011	WO2011097594A2 Therapeutic methods and compositions involving allosteric kinase inhibition
08/11/2011	WO2011096697A2 Process for preparing voriconazole by using new intermediates
08/11/2011	WO2011095802A1 Hplc method for analyzing sunitinib
08/11/2011	WO2011095625A1 1,2,4-triazine-4-amine derivatives
08/11/2011	WO2011095045A1 Pyridinone amide derivatives, preparation methods and medical uses thereof
08/11/2011	WO2011058524A3 Crystalline forms of bosentan salts and processes for their preparation
08/11/2011	WO2010143170A3 Compounds useful for treating premature aging and in particular progeria
08/11/2011	US20110196153 Processes of synthesizing dihydropyridophthalazinone derivatives
08/11/2011	US20110196147 Inhibitors of histone deacetylase
08/11/2011	US20110195978 Compounds for treatment of alzheimer's disease
08/11/2011	US20110195977 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
08/11/2011	US20110195973 Cyclic substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity

1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 626